Purdue was instrumental in creating the US opioid crisis via aggressive marketing that did not reflect the true addiction ...

Purdue Pharma said on Friday it needs more time to build support for a new $7.4 billion settlement that could complete the ...

Objections to Johnson & Johnson's talc bankruptcy plan cite the U.S. Supreme Court's decision last year invalidating nonconsensual releases in Purdue Pharma's $6 billion opioid settlement.

Colorado is set to receive around $81 million from a $7.4 billion preliminary settlement with Purdue Pharma, the company’s ...

Bankrupt Purdue Pharma LP and its owners have agreed to over $7 billion settlement to resolve lawsuits over OxyContin's role ...

NEW YORK (Reuters) - Purdue Pharma said on Friday it needs more ... several states' attorneys general and would propose a formal bankruptcy plan before the end of February. U.S. Bankruptcy Judge ...

Members of the Sackler family who own OxyContin maker Purdue Pharma, and the company itself, agreed to pay up to $7.4 billion to settle lawsuits over the toll of the ...

Pennsylvania may receive up to $212 million over 15 years as part of a multi-state lawsuit settlement with Purdue Pharma and ...

Purdue Pharma’s owners in the Sackler family have agreed to a new $6.5 billion settlement to lawsuits over their role in the U.S. opioid crisis. This comes after a previous deal was rejected by the ...

This story incorporates reporting fromBoston.com, Philadelphia Inquirer, The Boston Globe, pharmaphorum, Hartford Courant, ...